| 1 | characteristics | 22,678 |
| 2 | age/gender | 3 |
| 3 | accrual/loss | 2 |
| 4 | characteristics/demographics | 2 |
| 5 | dodoneifolius | 2 |
| 6 | offshoot | 2 |
| 7 | questionnary | 2 |
| 8 | work-hours | 2 |
| 9 | +1·3 | 1 |
| 10 | +4·2 | 1 |
| 11 | +5.79 | 1 |
| 12 | 1.15+/-0.27 | 1 |
| 13 | 12.64+/-2.92 | 1 |
| 14 | 12minutes/day | 1 |
| 15 | 13.48+/-2.86 | 1 |
| 16 | 2.73+/-1.56 | 1 |
| 17 | 24+/-9.4 | 1 |
| 18 | 4.11+/-0.85 | 1 |
| 19 | 6.52+/-0.92 | 1 |
| 20 | 71.11±3.23 | 1 |
| 21 | 8.1±2.9 | 1 |
| 22 | blood-pressures | 1 |
| 23 | bmi/bodyweight | 1 |
| 24 | charactistics | 1 |
| 25 | depression/impulsivity | 1 |
| 26 | log-ferritin | 1 |
| 27 | mri-flair | 1 |
| 28 | nonhallucinators | 1 |
| 29 | nt-pronbp | 1 |
| 30 | oschman | 1 |
| 31 | pancreaticamylase | 1 |
| 32 | recession- | 1 |
| 33 | responsibilisation | 1 |
| 34 | risks.there | 1 |
| 35 | self-modulation | 1 |
| 36 | serum-level | 1 |
| 37 | t1-t0 | 1 |
| 38 | was.19 | 1 |
| 1 | +1·3 | 1 |
| 2 | +4·2 | 1 |
| 3 | +5.79 | 1 |
| 4 | 1.15+/-0.27 | 1 |
| 5 | 12.64+/-2.92 | 1 |
| 6 | 12minutes/day | 1 |
| 7 | 13.48+/-2.86 | 1 |
| 8 | 2.73+/-1.56 | 1 |
| 9 | 24+/-9.4 | 1 |
| 10 | 4.11+/-0.85 | 1 |
| 11 | 6.52+/-0.92 | 1 |
| 12 | 71.11±3.23 | 1 |
| 13 | 8.1±2.9 | 1 |
| 14 | accrual/loss | 2 |
| 15 | age/gender | 3 |
| 16 | blood-pressures | 1 |
| 17 | bmi/bodyweight | 1 |
| 18 | characteristics | 22,678 |
| 19 | characteristics/demographics | 2 |
| 20 | charactistics | 1 |
| 21 | depression/impulsivity | 1 |
| 22 | dodoneifolius | 2 |
| 23 | log-ferritin | 1 |
| 24 | mri-flair | 1 |
| 25 | nonhallucinators | 1 |
| 26 | nt-pronbp | 1 |
| 27 | offshoot | 2 |
| 28 | oschman | 1 |
| 29 | pancreaticamylase | 1 |
| 30 | questionnary | 2 |
| 31 | recession- | 1 |
| 32 | responsibilisation | 1 |
| 33 | risks.there | 1 |
| 34 | self-modulation | 1 |
| 35 | serum-level | 1 |
| 36 | t1-t0 | 1 |
| 37 | was.19 | 1 |
| 38 | work-hours | 2 |
| 1 | recession- | 1 |
| 2 | t1-t0 | 1 |
| 3 | 6.52+/-0.92 | 1 |
| 4 | 12.64+/-2.92 | 1 |
| 5 | +4·2 | 1 |
| 6 | 71.11±3.23 | 1 |
| 7 | +1·3 | 1 |
| 8 | 24+/-9.4 | 1 |
| 9 | 4.11+/-0.85 | 1 |
| 10 | 2.73+/-1.56 | 1 |
| 11 | 13.48+/-2.86 | 1 |
| 12 | 1.15+/-0.27 | 1 |
| 13 | 8.1±2.9 | 1 |
| 14 | was.19 | 1 |
| 15 | +5.79 | 1 |
| 16 | risks.there | 1 |
| 17 | pancreaticamylase | 1 |
| 18 | serum-level | 1 |
| 19 | oschman | 1 |
| 20 | log-ferritin | 1 |
| 21 | self-modulation | 1 |
| 22 | responsibilisation | 1 |
| 23 | nt-pronbp | 1 |
| 24 | age/gender | 3 |
| 25 | mri-flair | 1 |
| 26 | characteristics/demographics | 2 |
| 27 | characteristics | 22,678 |
| 28 | charactistics | 1 |
| 29 | blood-pressures | 1 |
| 30 | nonhallucinators | 1 |
| 31 | work-hours | 2 |
| 32 | accrual/loss | 2 |
| 33 | dodoneifolius | 2 |
| 34 | bmi/bodyweight | 1 |
| 35 | offshoot | 2 |
| 36 | 12minutes/day | 1 |
| 37 | questionnary | 2 |
| 38 | depression/impulsivity | 1 |